Nebulized inhalation therapy is a common treatment for respiratory diseases. In order to reduce the risk of cross-infection during in-hospital diagnosis and treatment, and at the same time save the time of queuing for treatment, home nebulizers have been favored by many consumers in recent years, and the demand has increased greatly. In the recent "6.18" e-commerce shopping festival, Dongguan Jiaruikang Medical Technology Co., Ltd., a medical technology company located in Chashan, Dongguan, has achieved unexpected results on the e-commerce platform, and the children's nebulizer produced by the company has entered the TOP4 of the high-end nebulizer sales list on the e-commerce platform.
Children's special atomizer "6.18" sold nearly 20 million yuan
Dongguan Jiaruikang Medical Technology Co., Ltd. (hereinafter referred to as "Jiaruikang Medical"), located in the "Dongguan Digital Valley" park in Chashan, launched China's first children's special atomizer in 2023, and during this year's "6.18" period, this product reached the TOP4 in the field of high-end atomizer products of "Jingdong" and "Tmall", achieving sales of nearly 20 million yuan. Chen Yu, the general manager of the company, also entered the live broadcast room to participate in the "bringing goods" on the day of "6.18" and completed the first live broadcast of "Douyin".
In everyone's previous cognition, how can professional medical devices be bought on e-commerce platforms? This is also Chen Yu's concern, "In the past, the concept of 'serious medical treatment' made us all think that it was impossible for medical devices to enter the e-commerce sector. However, with the economic development and changes in the market environment, more and more people choose to consume on e-commerce platforms, which makes us feel that we must start to deploy e-commerce. Chen Yu said.
In February 2023, the company began to prepare for an e-commerce operation team, which experienced the first "6.18" last year, and its sales volume was outside the top 100 on the list; However, this year, with this special nebulizer for children, it has achieved explosive growth. Chen Yu believes that thanks to the vertical platform of e-commerce, their professional products can be recognized by more consumers.
More than 20 years of experience in the atomizer industry has reached the top level in China
Founded in 2003, Jiaruikang Medical has more than 20 years of experience in the nebulizer industry, from the early OEM production, to the current service provider providing integrated solutions for respiratory comprehensive diagnosis and treatment, covering in vitro diagnosis, clinical diagnosis, respiratory disease treatment, intensive care, respiratory rehabilitation and other links. In addition, an intelligent nebulization center has been built, relying on a set of respiratory chronic disease management information management system that includes intelligent nebulization equipment, big data visualization platform, and management center, which can provide intelligent and efficient technical service support for medical institutions.
At present, Jiaruikang Medical has cooperated with more than 4,000 hospitals across the country, and has the largest share of medical nebulizers in China. As a technology company focusing on drive technology, Jiaruikang Medical has 2 respiratory laboratories, 3 doctoral teams, and several school-enterprise cooperation projects, and has always been driven by innovation, constantly promoting and expanding new product lines, realizing "clinical demand-oriented" high-end respiratory diagnosis and treatment equipment innovation, and achieving the top level in China by virtue of its advantages of independence, intelligence, and digitalization.
Chen Yu said that the new children's special atomizer launched last year has reached the standard of medical grade in terms of product noise, product material safety, and effective particle data. The company has the only NGI simulated artificial lung laboratory in China, which can adjust the atomized particles according to demand. After many experimental adjustments, the atomized particles of this special nebulizer for children are 2.88 microns, which is more suitable for children's inhalation, with an effective inhalation particle accounting for 82.5%, and the utilization rate of drugs is higher, which can also shorten the course of children's disease. In addition, the noise level of the product is less than 43 decibels, which is at least 10 decibels lower than that of other brand products. Chen Yu said.
From the "big atomization" strategy to the "big breathing" field
In order to expand its development, Jiaruikang Medical will relocate to Chashan, Dongguan in August 2022, and will begin to lay out automated production in May 2023, and the first phase of automation equipment will be completed and put into use this year. "Our goal is to invest at least 10 million yuan per year in automation transformation within three years to improve production efficiency and production quality. In addition, the production environment of medical supplies is very important, and after automation, the on-site production environment can also be more precisely controlled, which is also more in line with the development requirements of the medical industry. Chen Yu said.
Regarding the medium and long-term development plan, Chen Yu revealed that the company will gradually enter the field of "big breathing" from the current "big atomization" strategy. "There are many products involved in the respiratory field, and we are currently seeking domestic substitutions in all aspects from detection and treatment to rehabilitation, such as EIT lung imaging system, insufflation lung cancer screening, and the world's smallest head-mounted non-inductive ventilator, etc., are all products that we will launch soon, so as to fill our product chain in the 'breathing' track."
Southern + reporter Qiu Xiangming
Correspondents: Li Qiuzhi, Xie Ruijian
【Author】 Qiu Xiangming
[Source] Southern Press Media Group Southern + client